Track the 셀트리온제약 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has recorded 97 reports. Market capitalisation: €1,772.5bn. The latest transaction was disclosed on 10 April 2026 (Purchase). Among the most active insiders: 셀트리온. All data is free.
97
Insider Decl.
n/a
Thresholds
€16m
36 ops.
Buy Volume
n/a
4 ops.
Sell Volume
30Σ signal
Buys €16mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,449 of 29,062 companies
45.9
score / 100
Value
39
Quality
53
FCF yld3.5%
Earn yld2.0%
EV/EBITDA26.6x
ROE8.9%
Gross mgn31%
Net mgn7.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.